Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cutaneous sensory nociceptors are specialized primary afferent neurons that terminate in the skin and are responsible for detecting potentially damaging stimuli, such as extreme temperature, mechanical pressure, or chemical irritants [Dubin & Patapoutian, 2010]. These neurons convert noxious stimuli into electrical signals that are transmitted to the central nervous system, ultimately resulting in the perception of pain [Basbaum et al., 2009]. While they are essential for protective reflexes and avoiding injury, their sensitization or dysfunction plays a central role in chronic and neuropathic pain conditions [Gold & Gebhart, 2010]. Pharmacological interventions often target specific ion channels and receptors expressed on these fibers, such as voltage-gated sodium channels (e.g., Nav1.7, Nav1.8) and transient receptor potential (TRP) channels (e.g., TRPV1), to modulate pain signaling [Wood et al., 2004]. Because cutaneous sensory nociceptors refers to a heterogeneous population of cells rather than a single protein, it is considered a physiological system rather than a discrete molecular target [StatPearls, 2023]. Consequently, drugs interacting with these nociceptors typically act on the various receptors and channels embedded within their membranes to achieve analgesic effects [Anand & Bley, 2011].
Modulation of ion channel activity, including voltage-gated sodium channel blockade and TRP channel activation or desensitization, to inhibit the generation and conduction of nociceptive signals [Anand & Bley, 2011; Wood et al., 2004].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cutaneous sensory nociceptor.